74 results
6-K
EX-99.1
TLSA
Tiziana Life Sciences Ltd
6 Jun 24
Report of Foreign Private Issuer
9:00am
medicine physician at Brigham and Women’s Hospital, a founding member of Mass General Brigham Healthcare System, and Associate Professor of Neurology
6-K
EX-99.1
TLSA
Tiziana Life Sciences Ltd
4 Jun 24
Report of Foreign Private Issuer
9:00am
is a founding member of the Mass General Brigham healthcare system.
For further inquiries:
Tiziana Life Sciences Ltd
Paul Spencer, Business Development
6-K
TLSA
Tiziana Life Sciences Ltd
30 May 24
Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research
7:00am
of Mass General Brigham healthcare system, is being honored with the prestigious “Giants of MS” award for his outstanding contributions in the area
6-K
EX-99.1
TLSA
Tiziana Life Sciences Ltd
30 May 24
Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research
7:00am
of the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital, a founding member of Mass General Brigham healthcare system, is being
6-K
EX-99.1
nrbu396a9bzwi8kybpp
25 Apr 24
Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab
10:00am
6-K
EX-99.1
uab 4b2qt615psn37p4
23 Apr 24
Report of Foreign Private Issuer
7:00am
6-K
EX-99.1
mlt 09z23q0y63
22 Apr 24
Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in its Expanded Access Program
10:10am
6-K
EX-99.1
vrtk8e4zan66j1ti
19 Apr 24
Report of Foreign Private Issuer
7:00am
6-K
EX-99.1
67hke
18 Apr 24
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
7:00am
6-K
EX-99.1
4oc8y81yhm
11 Apr 24
Report of Foreign Private Issuer
7:00am
6-K
EX-99.1
8mytim2xusf
8 Jan 24
Tiziana Life Sciences Announces Updated Clinical and PET Scan Findings for Intranasal Foralumab in Two New Multiple Sclerosis Patients
7:00am
6-K
EX-99.1
5e3ehiv96f
5 Jan 24
Report of Foreign Private Issuer
7:00am
6-K
EX-99.1
0bqbw
29 Dec 23
Updated Interim Results for the Six Months Ended 30 June 2023
4:30pm
6-K
EX-99.1
slzqkdc
19 Dec 23
Report of Foreign Private Issuer
7:00am
6-K
u1lmefswbthlzvg5s
30 Nov 23
Tiziana Life Sciences Announces Foralumab Dosing of Four New Patients in the Expanded Access Program for Multiple Sclerosis
7:08am
6-K
EX-99.1
e3g0b
30 Nov 23
Tiziana Life Sciences Announces Foralumab Dosing of Four New Patients in the Expanded Access Program for Multiple Sclerosis
7:08am
6-K
EX-99.1
9kpz656cv17ph
18 Oct 23
Tiziana Life Sciences Announces Allowance By FDA For At-Home Dosing Of Intranasal Foralumab For Multiple Sclerosis Treatment
7:12am
6-K
EX-99.1
t6t1utpi3i rrl22xig
16 Oct 23
Tiziana Life Sciences Announces Positive Six-Month Clinical Results in Multiple Sclerosis Patients Treated with Intranasal Foralumab
7:00am
6-K
EX-99.1
q847aavfnvkj
13 Oct 23
Report of Foreign Private Issuer
7:00am